Hatae M, Tezuka H, Ushiki N, Ezono Y, Igyuin H, Terahara M, Hokanishi H
Gan To Kagaku Ryoho. 1984 Mar;11(3):433-9.
We administrated cis-platinum 70-100 mg/m2 bolus, intraperitoneally or intrapleurally without diluting in saline, simultaneously combined with intravenous injection of sodium thiosulphate 1 gr/hr for 12 hours continuously or additional loading of sodium thiosulphate 4-6 g bolus on the initiation. The procedure does not require transfusion of specific hydration and keeps urine volume at a certain level, much less diuretics. For the treatment of 6 gynecological malignancies (2 primary ovarian carcinoma, 1 recurrent ovarian carcinoma, 1 pseudomyxoma peritonei, 1 clear cell carcinoma of cul de sac and 1 metastatic pleuritis carcinomatosa due to uterine cervical carcinoma) 12 courses treatments have been performed, without inducing nephrotoxicity except mild vomiting. All six cases are evaluable for efficacy according to Saito-Koyama criteria at this time: 4 CRs including 2 CRs for ascites and pleural effusion, 1 NC and 1 PD. This Two-Channel Chemotherapy (TCC) seems to be an important modality of chemotherapy for ovarian carcinoma in future.
我们腹腔内或胸腔内注射顺铂70 - 100 mg/m²大剂量推注,不稀释于生理盐水中,同时静脉注射硫代硫酸钠1克/小时,持续12小时,或在开始时额外推注4 - 6克硫代硫酸钠。该操作不需要特定的水化输血,可将尿量维持在一定水平,利尿剂使用更少。对于6例妇科恶性肿瘤(2例原发性卵巢癌、1例复发性卵巢癌、1例腹膜假黏液瘤、1例阴道穹窿透明细胞癌和1例因子宫颈癌导致的转移性胸膜癌)进行了12个疗程的治疗,除轻度呕吐外未诱发肾毒性。目前根据Saito - Koyama标准,所有6例病例均可评估疗效:4例完全缓解,其中包括2例腹水和胸腔积液完全缓解,1例病情稳定,1例病情进展。这种双通道化疗(TCC)似乎是未来卵巢癌化疗的一种重要方式。